YTEN - Yield10 Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
7.2M
Enterprise Value 3
9.88M
Trailing P/E
N/A
Forward P/E 1
-1.37
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
11.02
Price/Book (mrq)
1.62
Enterprise Value/Revenue 3
15.12
Enterprise Value/EBITDA 6
-1.20

Trading Information

Stock Price History

Beta (3Y Monthly) 1.57
52-Week Change 3-55.28%
S&P500 52-Week Change 37.98%
52 Week High 31.7700
52 Week Low 30.5000
50-Day Moving Average 30.6591
200-Day Moving Average 30.8935

Share Statistics

Avg Vol (3 month) 3175.16k
Avg Vol (10 day) 374.65k
Shares Outstanding 512.52M
Float 9.45M
% Held by Insiders 129.65%
% Held by Institutions 17.26%
Shares Short (Sep 30, 2019) 4329.32k
Short Ratio (Sep 30, 2019) 43.89
Short % of Float (Sep 30, 2019) 43.99%
Short % of Shares Outstanding (Sep 30, 2019) 42.63%
Shares Short (prior month Aug 30, 2019) 4439.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3May 30, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,295.56%

Management Effectiveness

Return on Assets (ttm)-45.65%
Return on Equity (ttm)-122.78%

Income Statement

Revenue (ttm)653k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)11.60%
Gross Profit (ttm)-4.2M
EBITDA -8.26M
Net Income Avi to Common (ttm)-8.62M
Diluted EPS (ttm)-0.8010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.25M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)6.06M
Total Debt/Equity (mrq)136.08
Current Ratio (mrq)3.33
Book Value Per Share (mrq)0.36

Cash Flow Statement

Operating Cash Flow (ttm)-7.94M
Levered Free Cash Flow (ttm)-5.33M